Literature DB >> 2371196

Acute lymphadenopathy complicating quinidine therapy.

C P Lau1, K L Wong, C K Wong, W H Leung.   

Abstract

A patient is described with quinidine-induced acute lymphadenopathy syndrome proven by rechallenge of the drug. Serum markers for systemic lupus were negative.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2371196      PMCID： PMC2426849          DOI： 10.1136/pgmj.66.775.406

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  Quinidine-induced reactive lymphadenopathy.

Authors:  H McGrath
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

2.  Hydantoin-induced pseudo-pseudolymphoma.

Authors:  R A Gams; J A Neal; F G Conrad
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

3.  Phenytoin and generalized lymphadenopathy.

Authors:  N L Harris; D J Widder
Journal:  Arch Pathol Lab Med       Date:  1983-12       Impact factor: 5.534

4.  Lymphadenopathy associated with diphenylhydantoin therapy.

Authors:  R P Abratt; R Sealy; C J Uys; R Lawson
Journal:  Clin Oncol       Date:  1982-12

5.  Quinidine-induced lupus erythematosus.

Authors:  S G West; M McMahon; J P Portanova
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

6.  Quinidine-induced reactive lymphadenopathy.

Authors:  R G Gay; K L Fielder; T M Grogan
Journal:  Am J Med       Date:  1987-01       Impact factor: 4.965

7.  Systemic lupus erythematosus (SLE) induced by quinidine.

Authors:  C J Lavie; J Biundo; R J Quinet; J Waxman
Journal:  Arch Intern Med       Date:  1985-03

8.  Phenytoin-induced lymphadenopathy.

Authors:  T L Schwinghammer; D L Howrie
Journal:  Drug Intell Clin Pharm       Date:  1983-06
  8 in total
  1 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.